Comparison of effect of methyl phenidate (Ritalin) and bupropion in children with hyperactivity disorder
Phase 3
- Conditions
- attention deficit hyperactivity disorder.Disturbance of activity and attention
- Registration Number
- IRCT201012295500N1
- Lead Sponsor
- Research vice chancellor of Mashad university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1-Children 6 to 12 years old with diagnosis of ADHD on the basis of DSM-IV-TR; 2-children without MR (IQ>70); 3-children without medical and neurologic problems specially with a history of epilepsy; 4-children without eating disorders (because of being prone to seizure due to bupropion); 5-agreement of parents in research participation; 6-the child that does not have the history of using Methyl phenidate and Bupropion and other psychiatric drugs. Exclusion criteria: 1-disagreement of parents during the research; 2-existance of severe side effects like neurologic disorders such as convulsion in curing groups.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of children (C-GAS). Timepoint: Before intervention, the fourth week and eighth week after the start of intervention. Method of measurement: Teacher and parent questionnaire.;Attention Deficit, hyperactivity Disorder Scale. Timepoint: Before intervention, the fourth week and eighth week after the start of intervention. Method of measurement: Teacher and parent questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects of bupropion. Timepoint: the fourth week and eighth week after the start of intervention. Method of measurement: Questionnaire check list.;Side effects of stimulant drugs. Timepoint: the fourth week and eighth week after the start of intervention. Method of measurement: Questionnaire check list.